Skip to main content
Top
Published in: Virology Journal 1/2007

Open Access 01-12-2007 | Research

Structure-based engineering of papillomavirus major capsid L1: controlling particle assembly

Authors: Brooke Bishop, Jhimli Dasgupta, Xiaojiang S Chen

Published in: Virology Journal | Issue 1/2007

Login to get access

Abstract

The outer shell of the papillomavirus particle is comprised of 72 pentamers of the major capsid L1 protein arranged on a T = 7 icosahedral lattice. The recombinant L1 can form T = 7 virus-like particles in vitro. The crystal structure of a T = 7 papilloma virion has not yet been determined; however, the crystal structure of a T = 1 particle containing 12 pentamers is known. The T = 1 structure reveals that helix-helix interactions, through three helices–h2, h3, and h4–near the C-terminus of L1, mediate the inter-pentameric bonding that is responsible for T = 1 assembly. Based on the T = 1 crystal structure, we have generated a set of internal deletions to test the role of the three C-terminal helices in T = 7 assembly. We have demonstrated that the h2, h3, and h4 near the C-terminal end of L1 are important for the L1 structure and particle assembly. In particular, we found that h2 and h3 are essential for L1 folding and pentamer formation, whereas h4 is indispensable for the assembly of not only T1, but also of the T7 virus-like particle.
Appendix
Available only for authorised users
Literature
1.
go back to reference Howley PM, Lowy DR: Papillomavirinae. In Fields Virology. Volume 1. Forth edition. Edited by: Knipe DM and Howley PM. Philadelphia, Lippincott Williams&Wilkins; 2001:2197-2130. Howley PM, Lowy DR: Papillomavirinae. In Fields Virology. Volume 1. Forth edition. Edited by: Knipe DM and Howley PM. Philadelphia, Lippincott Williams&Wilkins; 2001:2197-2130.
2.
go back to reference Cole C, Conzen SD: Polyomaviruses. In Fields Virology. Volume 2. Fourth edition. Edited by: Knipe DM and Howley PM. Philadelphia, Lippincott Williams&Wilkins; 2001:2141-2174. Cole C, Conzen SD: Polyomaviruses. In Fields Virology. Volume 2. Fourth edition. Edited by: Knipe DM and Howley PM. Philadelphia, Lippincott Williams&Wilkins; 2001:2141-2174.
3.
go back to reference Hagensee ME, Yaegashi N, Galloway DA: Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol 1993, 67: 315-322.PubMedPubMedCentral Hagensee ME, Yaegashi N, Galloway DA: Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol 1993, 67: 315-322.PubMedPubMedCentral
4.
go back to reference Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 1992, 89: 12180-12184. 10.1073/pnas.89.24.12180PubMedPubMedCentralCrossRef Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 1992, 89: 12180-12184. 10.1073/pnas.89.24.12180PubMedPubMedCentralCrossRef
5.
go back to reference Zhou J, Stenzel DJ, Sun XY, Frazer IH: Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J Gen Virol 1993, 74: 763-768.PubMedCrossRef Zhou J, Stenzel DJ, Sun XY, Frazer IH: Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J Gen Virol 1993, 74: 763-768.PubMedCrossRef
6.
go back to reference Sapp M, Volpers C, Streeck RE: Synthesis, properties and applications of papillomavirus-like particles. Intervirology 1996, 39: 49-53.PubMed Sapp M, Volpers C, Streeck RE: Synthesis, properties and applications of papillomavirus-like particles. Intervirology 1996, 39: 49-53.PubMed
7.
go back to reference Li M, Cripe TP, Estes PA, Lyon MK, Rose RC, Garcea RL: Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly. J Virol 1997, 71: 2988-2995.PubMedPubMedCentral Li M, Cripe TP, Estes PA, Lyon MK, Rose RC, Garcea RL: Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly. J Virol 1997, 71: 2988-2995.PubMedPubMedCentral
8.
go back to reference Rossi JL, Gissmann L, Jansen K, Muller M: Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae. Hum Gene Ther 2000, 11: 1165-1176. 10.1089/10430340050015211PubMedCrossRef Rossi JL, Gissmann L, Jansen K, Muller M: Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae. Hum Gene Ther 2000, 11: 1165-1176. 10.1089/10430340050015211PubMedCrossRef
9.
go back to reference Stauffer Y, Raj K, Masternak K, Beard P: Infectious human papillomavirus type 18 pseudovirions. J Mol Biol 1998, 283: 529-536. 10.1006/jmbi.1998.2113PubMedCrossRef Stauffer Y, Raj K, Masternak K, Beard P: Infectious human papillomavirus type 18 pseudovirions. J Mol Biol 1998, 283: 529-536. 10.1006/jmbi.1998.2113PubMedCrossRef
10.
go back to reference Chen X, Garcea R, Golderg I, Casini G, Harrison SC: Structure of Small Virus-like Particles Assembled from the L1 protein of Hunan Papillomavirus 16. Molecular Cell 2000, 5: 557-567. 10.1016/S1097-2765(00)80449-9PubMedCrossRef Chen X, Garcea R, Golderg I, Casini G, Harrison SC: Structure of Small Virus-like Particles Assembled from the L1 protein of Hunan Papillomavirus 16. Molecular Cell 2000, 5: 557-567. 10.1016/S1097-2765(00)80449-9PubMedCrossRef
11.
go back to reference Chen X, Casini G, Harrison SC, Garcea R: Papillomavirus Capsid Protein Expression in Escherichia coli: Purification and Assembly of HPV11 and HPV16 L1. J Mol Biol 2001, 307: 173-182. 10.1006/jmbi.2000.4464PubMedCrossRef Chen X, Casini G, Harrison SC, Garcea R: Papillomavirus Capsid Protein Expression in Escherichia coli: Purification and Assembly of HPV11 and HPV16 L1. J Mol Biol 2001, 307: 173-182. 10.1006/jmbi.2000.4464PubMedCrossRef
12.
go back to reference Trus BL, Roden RB, Greenstone HL, Vrhel M, Schiller JT, Booy FP: Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution. Nat Struct Biol 1997, 4: 413-420. 10.1038/nsb0597-413PubMedCrossRef Trus BL, Roden RB, Greenstone HL, Vrhel M, Schiller JT, Booy FP: Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution. Nat Struct Biol 1997, 4: 413-420. 10.1038/nsb0597-413PubMedCrossRef
14.
go back to reference Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, Harrison SC: Structure of simian virus 40 at 3.8-A resolution. Nature 1991, 354: 278-284. 10.1038/354278a0PubMedCrossRef Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, Harrison SC: Structure of simian virus 40 at 3.8-A resolution. Nature 1991, 354: 278-284. 10.1038/354278a0PubMedCrossRef
15.
go back to reference Stehle T, Yan Y, Benjamin TL, Harrison SC: Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 1994, 369: 160-163. 10.1038/369160a0PubMedCrossRef Stehle T, Yan Y, Benjamin TL, Harrison SC: Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 1994, 369: 160-163. 10.1038/369160a0PubMedCrossRef
Metadata
Title
Structure-based engineering of papillomavirus major capsid L1: controlling particle assembly
Authors
Brooke Bishop
Jhimli Dasgupta
Xiaojiang S Chen
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2007
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-4-3

Other articles of this Issue 1/2007

Virology Journal 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine